Option chain shows key data for Hemogenyx Pharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Hemogenyx Pharmaceuticals.

Hemogenyx Pharmaceuticals (OTC:HOPHF) Stock, Option Chain

Hemogenyx Pharmaceuticals PLC is a clinical-stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune diseases and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases. The company is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.

HEMOGENYX PHARMA PLC by HEMOGENYX PHARMACEUTICALS PLC.

Hemogenyx Pharmaceuticals PLC

Legal

Press Releases

Hemogenyx Pharmaceuticals PLC Announces Ultrafast CAR-T Manufacturing

Hemogenyx Pharmaceuticals PLC Announces Opening of First Clinical Site

Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes

Hemogenyx Pharmaceuticals PLC Announces First-in-Human Treatment with HG-CT-1

Hemogenyx Pharmaceuticals PLC Announces Institutional Investment

Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials

Hemogenyx Pharmaceuticals PLC Announces First Patient Safety

Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights

News

Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report

Hemogenyx Pharmaceuticals PLC Announces Final Results

HOPHF

Hemogenyx Pharmaceuticals

Comments

Hemogenyx Pharmaceuticals

Hemogenyx Pharmaceuticals (HOPHF) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell